Search

Your search keyword '"Smits, Anke B."' showing total 11 results
Start Over Author "Smits, Anke B." Database Supplemental Index
11 results on '"Smits, Anke B."'

2. Better stoma care using the Stoma App: does it help? A first randomized double-blind clinical trial on the effect of mobile healthcare on quality of life in stoma patients

Author

van der Storm, Sebastiaan L., Consten, Esther C. J., Govaert, Marc J. P. M., Tuynman, Jurriaan B., Oosterling, Steven J., Grotenhuis, Brechtje A., Smits, Anke B., Marsman, Hendrik A., van Rossem, Charles C., van Duyn, Eino B., de Nes, Lindsey C. F., Verdaasdonk, Emiel, de Vries Reilingh, Tammo S., Vening, Wouter, Bemelman, Willem A., and Schijven, Marlies P.

Abstract

Background: Receiving a stoma significantly impacts patients’ quality of life. Coping with this new situation can be difficult, which may result in a variety of physical and psychosocial problems. It is essential to provide adequate guidance to help patients cope with their stoma, as this positively influences self-efficacy in return. Higher self-efficacy reduces psychosocial problems increasing patient’s quality of life. This study investigates whether a new mobile application, the Stoma App, improves quality of life. And if personalized guidance, timed support, and peer contact offered as an in-app surplus makes a difference. Methods: A double-blind, randomized controlled trial was conducted between March 2021 and April 2023. Patients aged > 18 years undergoing ileostomy or colostomy surgery, in possession of a compatible smartphone were included. The intervention group received the full version of the app containing personalized and time guidance, peer support, and generic (non-personalized) stoma-related information. The control group received a restricted version with only generic information. Primary outcome was stoma quality of life. Secondary outcomes included psychological adaption, complications, re-admittance, reoperations, and length of hospital stay. Results: The intervention version of the app was used by 96 patients and the control version by 112 patients. After correction for confounding, the intervention group reported a significant 3.1-point improvement in stoma-related quality of life one month postoperatively (p= 0.038). On secondary outcomes, no significant improvements could be retrieved of the intervention group. Conclusion: The Stoma App improves the quality of life of stoma patients. Peer support and personalized guidance are of significant importance in building self-efficacy. It is to be recommended to implement Stoma app—freely available software qualifying as a medical device—in standard stoma care pathways for the benefits of both patients and healthcare providers.

Published
2024
Full Text
View/download PDF

3. Comparison of three-year oncological results after restorative low anterior resection, non-restorative low anterior resection and abdominoperineal resection for rectal cancer.

Author

Hol, Jeroen C., Burghgraef, Thijs A., Rutgers, Marieke L.W., Crolla, Rogier M.P.H., van Geloven, Nanette A.W., Leijtens, Jeroen W.A., Polat, Fatih, Pronk, Apollo, Smits, Anke B., Tuynman, Jurriaan B., Verdaasdonk, Emiel G.G., Consten, Esther C.J., Hompes, Roel, and Sietses, Colin

Subjects
ABDOMINOPERINEAL resection, RECTAL cancer, ONCOLOGIC surgery, PROGRESSION-free survival, REGRESSION analysis, OVERALL survival
Abstract

Oncological outcome might be influenced by the type of resection in total mesorectal excision (TME) for rectal cancer. The aim was to see if non-restorative LAR would have worse oncological outcome. A comparison was made between non-restorative low anterior resection (NRLAR), restorative low anterior resection (RLAR) and abdominoperineal resection (APR). This retrospective cohort included data from patients undergoing TME for rectal cancer between 2015 and 2017 in eleven Dutch hospitals. A comparison was made for each different type of procedure (APR, NRLAR or RLAR). Primary outcome was 3-year overall survival (OS). Secondary outcomes included 3-year disease-free survival (DFS) and 3-year local recurrence (LR) rate. Of 998 patients 363 underwent APR, 132 NRLAR and 503 RLAR. Three-year OS was worse after NRLAR (78.2%) compared to APR (86.3%) and RLAR (92.2%, p < 0.001). This was confirmed in a multivariable Cox regression analysis (HR 1.85 (1.07, 3.19), p = 0.03). The 3-year DFS was also worse after NRLAR (60.3%), compared to APR (70.5%) and RLAR (80.1%, p < 0.001), HR 2.05 (1.42, 2.97), p < 0.001. The LR rate was 14.6% after NRLAR, 5.2% after APR and 4.8% after RLAR (p = 0.005), HR 3.22 (1.61, 6.47), p < 0.001. NRLAR might be associated with worse 3-year OS, DFS and LR rate compared to RLAR and APR. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

5. Frailty and health related quality of life three months after non-metastatic colorectal cancer diagnosis in older patients: A multi-centre prospective observational study.

Author

van der Vlies, Ellen, Vernooij, Lisette M., Hamaker, Marije E., van der Velden, Ankie M.T., Smits, Marianne, Intven, Martijn P.W., van Dodewaard, Joyce M., Takkenberg, Marijn, Vink, Geraldine R., Smits, Anke B., Bos, Willem Jan W., van Dongen, Eric P.A., Los, Maartje, and Noordzij, Peter G.

Abstract

Health related quality of life (HRQL) is an important outcome measure in geriatric oncology. Surgery is the main treatment for colorectal cancer (CRC) but has been associated with a loss of HRQL in older patients. This study aimed to identify determinants for a decreased HRQL at three months after CRC diagnosis. This multi-centre observational cohort study (NCT04443816) included 273 patients aged ≥70 years diagnosed with non-metastatic CRC. A multi-domain frailty screening was performed in each patient. A decreased HRQL was defined as a mean difference ≥ 10 on the EORTC QLQ-C30 questionnaire between baseline and three months after CRC diagnosis. Determinants of a decreased HRQL were analysed using multivariable logistic regression. A decrease in HRQL occurred in 63 patients (23.1%). Non-surgical patients had the highest risk of decreased HRQL three months after diagnosis (adjusted odds ratio (OR) 6.4 (95% confidence interval (CI) 2.0–19.8)). The Charlson Comorbidity Index (CCI) (aOR 2.3 (95% (CI) 1.2–4.2)), the American Association of Anesthesiologists class (aOR 2.6 (95%CI 1.4–4.9)), impaired daily functioning (aOR 2.7 (95%CI 1.3–5.6)) and dependent living (aOR 1.9 (95%CI 1.1–4.5)) were associated with a decreased HRQL, mainly caused by non-surgical patients. In surgical patients, a major postoperative complication was a strong determinant of decreased HRQL and was associated with preoperative comorbidity and cognitive impairment (aOR 4.0 (95%CI 1.9–8.8)). Frailty characteristics are highly prevalent in older patients at time of CRC diagnosis but not strongly associated with a decreased HRQL after three months. Non-surgical patients and patients with major postoperative complications had the highest risk of decreased HRQL. Registered at clinicaltrials.gov trial number: NCT04443816 [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

6. Impact of a diverting ileostomy in total mesorectal excision with primary anastomosis for rectal cancer

Author

Hol, Jeroen C., Burghgraef, Thijs A., Rutgers, Marieke L. W., Crolla, Rogier M. P. H., van Geloven, Anna A. W., de Jong, Gabie M., Hompes, Roel, Leijtens, Jeroen W. A., Polat, Fatih, Pronk, Apollo, Smits, Anke B., Tuynman, Jurriaan B., Verdaasdonk, Emiel G. G., Consten, Esther C. J., and Sietses, Colin

Abstract

Background: The role of diverting ileostomy in total mesorectal excision (TME) for rectal cancer with primary anastomosis is debated. The aim of this study is to gain insight in the clinical consequences of a diverting ileostomy, with respect to stoma rate at one year and stoma-related morbidity. Methods: Patients undergoing TME with primary anastomosis for rectal cancer between 2015 and 2017 in eleven participating hospitals were included. Retrospectively, two groups were compared: patients with or without diverting ileostomy construction during primary surgery. Primary endpoint was stoma rate at one year. Secondary endpoints were severity and rate of anastomotic leakage, overall morbidity rate within thirty days and stoma (reversal) related morbidity. Results: In 353 out of 595 patients (59.3%) a diverting ileostomy was constructed during primary surgery. Stoma rate at one year was 9.9% in the non-ileostomy group and 18.7% in the ileostomy group (p = 0.003). After correction for confounders, multivariate analysis showed that the construction of a diverting ileostomy during primary surgery was an independent risk factor for stoma at one year (OR 2.563 (95%CI 1.424–4.611), p = 0.002). Anastomotic leakage rate was 17.8% in the non-ileostomy group and 17.2% in the ileostomy group (p = 0.913). Overall 30-days morbidity rate was 37.6% in the non-ileostomy group and 56.1% in the ileostomy group (p &lt; 0.001). Stoma reversal related morbidity rate was 17.9%. Conclusions: The stoma rate at one year was higher in patients with ileostomy construction during primary surgery. The incidence and severity of anastomotic leakage were not reduced by construction of an ileostomy. The morbidity related to the presence and reversal of a diverting ileostomy was substantial.

Published
2022
Full Text
View/download PDF

7. Implementation of a preoperative multidisciplinary team approach for frail colorectal cancer patients: Influence on patient selection, prehabilitation and outcome.

Author

van der Vlies, Ellen, Smits, Anke B., Los, Maartje, van Hengel, Marike, Bos, Willem Jan W., Dijksman, Lea M., van Dongen, Eric P.A., and Noordzij, Peter G.

Abstract

To determine the influence of a preoperative multidisciplinary evaluation for frail older patients with colorectal cancer (CRC) on preoperative decision making and postoperative outcomes. Surgery is the main treatment for CRC. Older patients are at increased risk for adverse outcomes. For complex surgical cases, a multidisciplinary team (MDT) approach has been suggested to improve postoperative outcome. Evidence is lacking. Historical cohort study from 2015 to 2018 in surgical patients ≥70 years with CRC. Frailty screening was used to appraise the somatic, functional and psychosocial health status. An MDT weighed the risk of surgery versus the expected gain in survival to guide preoperative decision making and initiate a prehabilitation program. Primary endpoint was the occurrence of a Clavien-Dindo (CD) Grade III-V complication. Secondary endpoints included the occurrence of any complication (CD II-V), length of hospital stay, discharge destination, readmission rate and overall survival. 466 patients were included and 146 (31.3%) patients were referred for MDT evaluation. MDT patients were more often too frail for surgery compared to non-MDT patients (10.3% vs 2.2%, P =.01). Frailty was associated with overall mortality (aOR 2.6 95% CI 1.1–6.1). Prehabilitation was more often performed in MDT patients (74.8% vs 23.4% in non-MDT patients). Despite an increased risk, MDT patients did not suffer more postoperative complications (CD III-V) than non-MDT patients (14.9% vs 12.4%; P =.48). Overall survival was worse in MDT patients (35 (32–37) vs 48 (47–50) months in non-MDT patients; P <.01). Implementation of preoperative MDT evaluation for frail patients with CRC improves risk stratification and prehabilitation, resulting in comparable postoperative outcomes compared to non-frail patients. However, frail patients are at increased risk for worse overall survival. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

8. The impact of postoperative complications on health-related quality of life in older patients with rectal cancer; a prospective cohort study.

Author

Couwenberg, Alice M., de Beer, Fleur S.A., Intven, Martijn P.W., Burbach, Johannes P.M., Smits, Anke B., Consten, Esther C.J., Schiphorst, Anandi H.W., Wijffels, Niels A.T., de Roos, Marnix A.J., Hamaker, Marije E., van Grevenstein, Wilhemina M.U., and Verkooijen, Helena M.

Abstract

Objectives As result of the aging population and increasing rectal cancer incidence, more older patients undergo treatment for rectal cancer. This study compares treatment course, postoperative complications, and quality of life (QOL) between older and younger patients with rectal cancer and evaluates the impact of postoperative complications on QOL in the elderly. Materials and Methods Patients with rectal cancer participating in a prospective colorectal cancer cohort and referred for radiotherapy between 2013 and 2016 were included. QOL was assessed with the cancer questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC QLQ-C30) before treatment and at three, six, and twelve months. Outcomes were compared between older patients (≥ 70 years) and younger patients (< 70 years) and stratified by presence of postoperative complications. Results In total, 115 (33%) older patients and 230 (67%) younger patients were included. Compared to younger patients, older patients underwent significantly more often short-course radiation with delayed surgery (6.1% and 19.1% respectively) and less often chemoradiation (62.6% and 39.1% respectively), and were more likely to undergo a Hartmann procedure with permanent stoma (3.5% and 13.0% respectively) instead of sphincter-sparing surgery (43.9% and 29.6% respectively). Postoperative complication rates were similar (38.5% in older patients versus 34.7% in younger patients). Older patients had worse physical functioning at six and twelve months after diagnosis compared to younger patients. Presence of postoperative complications had a significant stronger impact on physical- and role functioning in older patients. Conclusion Older patients undergo more often a tailored treatment approach for rectal cancer than younger patients. With this tailored approach, similar postoperative complication rates and QOL are achieved. However, postoperative complications have a larger negative impact on physical- and role functioning in older patients which indicates a need for better prediction of postoperative complications in the elderly. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

9. Comparison of MRI and colonoscopy in determining tumor height in rectal cancer

Author

Jacobs, Lotte, Meek, David B, Heukelom, Joost, Bollen, Thomas L, Siersema, Peter D, Smits, Anke B, Tromp, Ellen, Los, Maartje, Weusten, Bas LAM, and Lelyveld, Niels

Abstract

Endoscopy and magnetic resonance imaging (MRI) are used routinely in the diagnostic and preoperative work-up of rectal cancer. We aimed to compare colonoscopy and MRI in determining rectal tumor height. Between 2002 and 2012, all patients with rectal cancer with available MRIs and endoscopy reports were included. All MRIs were reassessed for tumor height by two abdominal radiologists. To obtain insight in techniques used for endoscopic determination of tumor height, a survey among regional endoscopists was conducted. A total of 211 patients with rectal cancer were included. Tumor height was significantly lower when assessed by MRI than by endoscopy with a mean difference of 2.5?cm (95% CI: 2.1–2.8). Although the agreement between tumor height as measured by MRI and endoscopy was good (intraclass correlation coefficient (ICC) 0.7 (95% CI: 0.7–0.8)), the 95% limits of agreement varied from –3.0?cm to 8.0?cm. In 45 patients (21.3%), tumors were regarded as low by MRI and middle–high by endoscopy. MRI inter- and intraobserver agreements were excellent with an ICC of 0.8 (95% CI: 0.7–0.9) and 0.9 (95% CI: 0.9–1.0), respectively. The survey showed no consensus among endoscopists as to how to technically measure tumor height. This study showed large variability in rectal tumor height as measured by colonoscopy and MRI. Since MRI measurements showed excellent inter- and intraobserver agreement, we suggest using tumor height measurement by MRI for diagnostic purposes and treatment allocation.

Published
2018
Full Text
View/download PDF

10. Comparison of MRI and colonoscopy in determining tumor height in rectal cancer

Author

Jacobs, Lotte, Meek, David B, van Heukelom, Joost, Bollen, Thomas L, Siersema, Peter D, Smits, Anke B, Tromp, Ellen, Los, Maartje, Weusten, Bas LAM, and van Lelyveld, Niels

Abstract

Background and aim Endoscopy and magnetic resonance imaging (MRI) are used routinely in the diagnostic and preoperative work-up of rectal cancer. We aimed to compare colonoscopy and MRI in determining rectal tumor height.Methods Between 2002 and 2012, all patients with rectal cancer with available MRIs and endoscopy reports were included. All MRIs were reassessed for tumor height by two abdominal radiologists. To obtain insight in techniques used for endoscopic determination of tumor height, a survey among regional endoscopists was conducted.Results A total of 211 patients with rectal cancer were included. Tumor height was significantly lower when assessed by MRI than by endoscopy with a mean difference of 2.5 cm (95% CI: 2.1–2.8). Although the agreement between tumor height as measured by MRI and endoscopy was good (intraclass correlation coefficient (ICC) 0.7 (95% CI: 0.7–0.8)), the 95% limits of agreement varied from –3.0 cm to 8.0 cm. In 45 patients (21.3%), tumors were regarded as low by MRI and middle–high by endoscopy. MRI inter- and intraobserver agreements were excellent with an ICC of 0.8 (95% CI: 0.7–0.9) and 0.9 (95% CI: 0.9–1.0), respectively. The survey showed no consensus among endoscopists as to how to technically measure tumor height.Conclusion This study showed large variability in rectal tumor height as measured by colonoscopy and MRI. Since MRI measurements showed excellent inter- and intraobserver agreement, we suggest using tumor height measurement by MRI for diagnostic purposes and treatment allocation.

Published
2018
Full Text
View/download PDF

11. Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial

Author

Nauth, Aaron, Creek, Aaron T., Zellar, Abby, Lawendy, Abdel-Rahman, Dowrick, Adam, Gupta, Ajay, Dadi, Akhil, van Kampen, Albert, Yee, Albert, de Vries, Alexander C., de Mol van Otterloo, Alexander, Garibaldi, Alisha, Liew, Allen, McIntyre, Allison W., Prasad, Amal Shankar, Romero, Amanda W., Rangan, Amar, Oatt, Amber, Sanghavi, Amir, Foley, Amy L., Karlsten, Anders, Dolenc, Andrea, Bucknill, Andrew, Chia, Andrew, Evans, Andrew, Gong, Andrew, Schmidt, Andrew H., Marcantonio, Andrew J., Jennings, Andrew, Ward, Angela, Khanna, Angshuman, Rai, Anil, Smits, Anke B., Horan, Annamarie D., Brekke, Anne Christine, Flynn, Annette, Duraikannan, Aravin, Stødle, Are, van Vugt, Arie B., Luther, Arlene, Zurcher, Arthur W., Jain, Arvind, Amundsen, Asgeir, Moaveni, Ash, Carr, Ashley, Sharma, Ateet, Hill, Austin D., Trommer, Axel, Rai, B. Sachidananda, Hileman, Barbara, Schreurs, Bart, Verhoeven, Bart, Barden, Benjamin B., Flatøy, Bernhard, Cleffken, Berry I., Bøe, Berthe, Perey, Bertrand, Hanusch, Birgit C., Weening, Brad, Fioole, Bram, Rijbroek, Bram, Crist, Brett D., Halliday, Brett, Peterson, Brett, Mullis, Brian, Richardson, C. Glen, Clark, Callum, Sagebien, Carlos A., van der Pol, Carmen C., Bowler, Carol, Humphrey, Catherine A., Coady, Catherine, Koppert, Cees L., Coles, Chad, Tannoury, Chadi, DePaolo, Charles J., Gayton, Chris, Herriott, Chris, Reeves, Christina, Tieszer, Christina, Dobb, Christine, Anderson, Christopher G., Sage, Claire, Cuento, Claudine, Jones, Clifford B., Bosman, Coks H.R., Linehan, Colleen, van der Hart, Cor P., Henderson, Corey, Lewis, Courtland G., Davis, Craig A., Donohue, Craig, Mauffrey, Cyril, Sundaresh, D.C., Farrell, Dana J., Whelan, Daniel B., Horwitz, Daniel, Stinner, Daniel, Viskontas, Darius, Roffey, Darren M., Alexander, David, Karges, David E., Hak, David, Johnston, David, Love, David, Wright, David M., Zamorano, David P., Goetz, David R., Sanders, David, Stephen, David, Yen, David, Bardana, Davide, Olakkengil, Davy J, Lawson, Deanna, Maddock, Deborah, Sietsema, Debra L., Pourmand, Deeba, Den Hartog, Dennis, Donegan, Derek, Heels-Ansdell, Diane, Nam, Diane, Inman, Dominic, Boyer, Dory, Li, Doug, Gibula, Douglas, Price, Dustin M., Watson, Dylan J., Hammerberg, E. Mark, Tan, Edward T.C.H., de Graaf, Eelco J.R., Vesterhus, Elise Berg, Roper, Elizabeth, Edwards, Elton, Schemitsch, Emil H., Hammacher, Eric R., Henderson, Eric R., Whatley, Erica, Torres, Erick T., Vermeulen, Erik G.J., Finn, Erin, Van Lieshout, Esther M.M., Wai, Eugene K., Bannister, Evan R., Kile, Evelyn, Theunissen, Evert B.M., Ritchie, Ewan D., Khan, Farah, Moola, Farhad, Howells, Fiona, de Nies, Frank, van der Heijden, Frank H.W.M., de Meulemeester, Frank R.A.J., Frihagen, Frede, Nilsen, Fredrik, Schmidt, G. Ben, Albers, G.H. Robert, Gudger, Garland K., Johnson, Garth, Gruen, Gary, Zohman, Gary, Sharma, Gaurav, Wood, Gavin, Tetteroo, Geert W.M., Hjorthaug, Geir, Jomaas, Geir, Donald, Geoff, Rieser, Geoffrey Ryan, Reardon, Gerald, Slobogean, Gerard P., Roukema, Gert R, Visser, Gijs A., Moatshe, Gilbert, Horner, Gillian, Rose, Glynis, Guyatt, Gordon, Chuter, Graham, Etherington, Greg, Rocca, Gregory J. Della, Ekås, Guri, Dobbin, Gwendolyn, Lemke, H. Michael, Curry, Hamish, Boxma, Han, Gissel, Hannah, Kreder, Hans, Kuiken, Hans, Brom, Hans L.F., Pape, Hans-Christoph, van der Vis, Harm M, Bedi, Harvinder, Vallier, Heather A., Brien, Heather, Silva, Heather, Newman, Heike, Viveiros, Helena, van der Hoeven, Henk, Ahn, Henry, Johal, Herman, Rijna, Herman, Stockmann, Heyn, Josaputra, Hong A., Carlisle, Hope, van der Brand, Igor, Dawson, Imro, Tarkin, Ivan, Wong, Ivan, Parr, J. Andrew, Trenholm, J. Andrew, Goslings, J. Carel, Amirault, J. David, Broderick, J. Scott, Snellen, Jaap P., Zijl, Jacco A.C., Ahn, Jaimo, Ficke, James, Irrgang, James, Powell, James, Ringler, James R., Shaer, James, Monica, James T., Biert, Jan, Bosma, Jan, Brattgjerd, Jan Egil, Frölke, Jan Paul M., Wille, Jan, Rajakumar, Janakiraman, Walker, Jane E., Baker, Janell K., Ertl, Janos P., de Vries, Jean Paul P.M., Gardeniers, Jean W.M., May, Jedediah, Yach, Jeff, Hidy, Jennifer T., Westberg, Jerald R., Hall, Jeremy A., van Mulken, Jeroen, McBeth, Jessica Cooper, Hoogendoorn, Jochem, Hoffman, Jodi M., Cherian, Joe Joseph, Tanksley, John A., Clarke-Jenssen, John, Adams, John D., Esterhai, John, Tilzey, John F., Murnaghan, John, Ketz, John P., Garfi, John S., Schwappach, John, Gorczyca, John T., Wyrick, John, Rydinge, Jonas, Foret, Jonathan L., Gross, Jonathan M., Keeve, Jonathan P., Meijer, Joost, Scheepers, Joris J.G., Baele, Joseph, O'Neil, Joseph, Cass, Joseph R., Hsu, Joseph R., Dumais, Jules, Lee, Julia, Switzer, Julie A., Agel, Julie, Richards, Justin E., Langan, Justin W., Turckan, Kahn, Pecorella, Kaili, Rai, Kamal, Aurang, Kamran, Shively, Karl, van Wessem, Karlijn, Moon, Karyn, Eke, Kate, Erwin, Katie, Milner, Katrine, Ponsen, Kees Jan, Mills, Kelli, Apostle, Kelly, Johnston, Kelly, Trask, Kelly, Strohecker, Kent, Stringfellow, Kenya, Kruse, Kevin K., Tetsworth, Kevin, Mitchell, Khalis, Browner, Kieran, Hemlock, Kim, Carcary, Kimberly, Jørgen Haug, Knut, Noble, Krista, Robbins, Kristin, Payton, Krystal, Jeray, Kyle J., Rubino, L. Joseph, Nastoff, Lauren A., Leffler, Lauren C., Stassen, Laurents P.S., O'Malley, Lawrence K., Specht, Lawrence M., Thabane, Lehana, Geeraedts, Leo M.G., Shell, Leslie E., Anderson, Linda K., Eickhoff, Linda S., Lyle, Lindsey, Pilling, Lindsey, Buckingham, Lisa, Cannada, Lisa K., Wild, Lisa M., Dulaney-Cripe, Liz, Poelhekke, Lodewijk M.S.J., Govaert, Lonneke, Ton, Lu, Kottam, Lucksy, Leenen, Luke P.H., Clipper, Lydia, Jackson, Lyle T., Hampton, Lynne, de Waal Malefijt, Maarten C., Simons, Maarten P., van der Elst, Maarten, Bronkhorst, Maarten W.G.A., Bhatia, Mahesh, Swiontkowski, Marc, Lobo, Margaret J., Swinton, Marilyn, Pirpiris, Marinis, Molund, Marius, Gichuru, Mark, Glazebrook, Mark, Harrison, Mark, Jenkins, Mark, MacLeod, Mark, de Vries, Mark R., Butler, Mark S., Nousiainen, Markku, van 't Riet, Martijne, Tynan, Martin C., Campo, Martin, Eversdijk, Martin G., Heetveld, Martin J., Richardson, Martin, Breslin, Mary, Fan, Mary, Edison, Matt, Napierala, Matthew, Knobe, Matthias, Russ, Matthias, Zomar, Mauri, de Brauw, Maurits, Esser, Max, Hurley, Meghan, Peters, Melissa E., Lorenzo, Melissa, Li, Mengnai, Archdeacon, Michael, Biddulph, Michael, Charlton, Michael, McDonald, Michael D., McKee, Michael D., Dunbar, Michael, Torchia, Michael E., Gross, Michael, Hewitt, Michael, Holt, Michael, Prayson, Michael J., Edwards, Michael J.R., Beckish, Michael L., Brennan, Michael L., Dohm, Michael P., Kain, Michael S.H., Vogt, Michelle, Yu, Michelle, Verhofstad, Michiel H.J., Segers, Michiel J.M., Segers, Michiel J.M., Siroen, Michiel P.C., Reed, Mike, Vicente, Milena R., Bruijninckx, Milko M.M., Trivedi, Mittal, Bhandari, Mohit, Moore, Molly M., Kunz, Monica, Smedsrud, Morten, Palla, Naveen, Jain, Neeraj, Out, Nico J.M., Simunovic, Nicole, Simunovic, Nicole, Schep, Niels W.L., Müller, Oliver, Guicherit, Onno R., Van Waes, Oscar J.F., Wang, Otis, Doornebosch, Pascal G., Seuffert, Patricia, Hesketh, Patrick J., Weinrauch, Patrick, Duffy, Paul, Keller, Paul, Lafferty, Paul M., Pincus, Paul, Tornetta, Paul, Zalzal, Paul, McKay, Paula, Cole, Peter A., de Rooij, Peter D., Hull, Peter, Go, Peter M.N.Y.M., Patka, Peter, Siska, Peter, Weingarten, Peter, Kregor, Philip, Stahel, Philip, Stull, Philip, Wittich, Philippe, de Rijcke, Piet A.R., Oprel, Pim, Devereaux, PJ, Zhou, Qi, Lee Murphy, R., Alosky, Rachel, Clarkson, Rachel, Moon, Raely, Logishetty, Rajanikanth, Nanda, Rajesh, Sullivan, Raymond J., Snider, Rebecca G., Buckley, Richard E., Iorio, Richard, Farrugia, Richard J, Jenkinson, Richard, Laughlin, Richard, Groenendijk, Richard P.R., Gurich, Richard W., Worman, Ripley, Silvis, Rob, Haverlag, Robert, Teasdall, Robert J., Korley, Robert, McCormack, Robert, Probe, Robert, Cantu, Robert V., Huff, Roger B., Simmermacher, Rogier K.J., Peters, Rolf, Pfeifer, Roman, Liem, Ronald, Wessel, Ronald N., Verhagen, Ronald, Vuylsteke, Ronald, Leighton, Ross, McKercher, Ross, Poolman, Rudolf W., Miller, Russell, Bicknell, Ryan, Finnan, Ryan, Khan, Ryan M., Mehta, Samir, Vang, Sandy, Singh, Sanjay, Anand, Sanjeev, Anderson, Sarah A., Dawson, Sarah A., Marston, Scott B., Porter, Scott E., Watson, Scott T., Festen, Sebastiaan, Lieberman, Shane, Puloski, Shannon, Bielby, Shea A., Sprague, Sheila, Hess, Shelley, MacDonald, Shelley, Evans, Simone, Bzovsky, Sofia, Hasselund, Sondre, Lewis, Sophie, Ugland, Stein, Caminiti, Stephanie, Tanner, Stephanie L., Zielinski, Stephanie M., Shepard, Stephanie, Sems, Stephen A., Walter, Stephen D., Doig, Stephen, Finley, Stephen H., Kates, Stephen, Lindenbaum, Stephen, Kingwell, Stephen P., Csongvay, Steve, Papp, Steve, Buijk, Steven E., Rhemrev, Steven J., Hollenbeck, Steven M., van Gaalen, Steven M., Yang, Steven, Weinerman, Stuart, Subash, Lambert, Sue, Liew, Susan, Meylaerts, Sven A.G., Blokhuis, Taco J., de Vries Reilingh, Tammo S., Lona, Tarjei, Scott, Taryn, Swenson, Teresa K., Endres, Terrence J., Axelrod, Terry, van Egmond, Teun, Pace, Thomas B., Kibsgård, Thomas, Schaller, Thomas M., Ly, Thuan V., Miller, Timothy J., Weber, Timothy, Le, Toan, Oliver, Todd M., Karsten, Tom M., Borch, Tor, Hoseth, Tor Magne, Nicolaisen, Tor, Ianssen, Torben, Rutherford, Tori, Nanney, Tracy, Gervais, Trevor, Stone, Trevor, Schrickel, Tyson, Scrabeck, Tyson, Ganguly, Utsav, Naumetz, V., Frizzell, Valda, Wadey, Veronica, Jones, Vicki, Avram, Victoria, Mishra, Vimlesh, Yadav, Vineet, Arora, Vinod, Tyagi, Vivek, Borsella, Vivian, Willems, W. Jaap, Hoffman, W.H., Gofton, Wade T., Lackey, Wesley G., Ghent, Wesley, Obremskey, William, Oxner, William, Cross, William W., Murtha, Yvonne M., and Murdoch, Zoe

Abstract

Reoperation rates are high after surgery for hip fractures. We investigated the effect of a sliding hip screw versus cancellous screws on the risk of reoperation and other key outcomes.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results